1De Gualielmo M,Casolari C,Zanasi,E,et al.Sputum microbial pattern in severe exacerbations of COPD requiring non-invasive mechanical ventilation.Eur Respir J,2004,24(suppl 48):s312. 被引量：1
2Erkan L,Uzun O,Katar D,et al.Infective etiology of acute exacerbation of COPD (AECOPD).Eur Respir J,2004,24(suppl 48):s512. 被引量：1
3Lapteva IM,Lapteva EA,and Korovkin VS.Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD.Eur Respir J,2004,24(suppl 48):s408. 被引量：1
4Caparoska TB,Kneva BA,Gerovski BA,et al.Infectious exacerbations of COPD - connections between bacteriology and respiratory function.Eur Respir J,2004,24(suppl 48):s411. 被引量：1
5Wilkinson T,Powrie D,Wilks M,et al.Differential inflammatory effects of colonising airway bacteria in COPD.Eur Respir J,2004,24(suppl 48):s686. 被引量：1
6Powrie DJ,Wilkinson TM,Donaldson GC,et al.Chronic sputum production in COPD is a marker for airway inflammation and colonization.Eur Respir J,2004,24(suppl 48):s306. 被引量：1
7Soler N,Agusti C,Angrill J,et al.Validation of Anthonisen criteria in infectious COPD exacerbation among patients requiring hospitalization.Eur Respir J,2004,24(suppl 48):s411. 被引量：1
8Jaccard-Stolz D,Christ-Crain M,Gencay MM,et al.Indication for antibiotic therapy in AECB:anthonisen's criteria versus procalcitonin.Eur Respir J,2004,24(suppl 48):s50. 被引量：1
9Wilson R,Allegra L,Huchon G,et al.Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis.Chest,2004,125:953-964. 被引量：1
10Jones PW,Spencer S,Kuprat-Lomon I,et al.Value of measuring SGRQ at stable phase of COPD to predict the timing and deterioration associated with next exacerbation: the MOSAIC study.Eur Respir J,2004, 24(suppl 48):s240,s686. 被引量：1
